Why refer?

GenesisCare is the UK's leading independent cancer care provider. We specialise in advanced and innovative cancer diagnostics and treatments, and collaborate with health professionals who share our vision of enabling fast access to world-class cancer care. 

We work in partnership with our consultants to build a strong governance framework and to be the first to introduce many new cancer treatments safely and effectively. Our strategy is to invest early in new evidence-based treatments and modalities that hold potential for improved life outcomes. 

We believe care should be available when and where patients need it most and it should be designed to give patients the best outcomes possible. 

Advanced techniques and treatments

At our 14 oncology specialist private cancer centres throughout the UK, we provide the following cancer services:

• Stereotactic ablative radiotherapy (SABR), including complex SABR and MR Linacs for MRI-guided adaptive radiotherapy – the most important development in advanced radiation oncology in years
• Specialist neuro-oncology centres at Oxford and London, including Gamma Knife Icon, stereotactic radiosurgery (SRS), neurosurgery and fMRI and diffusion tractography diagnostics and treatment planning 
• Advanced IMRT/VMAT, together with SGRT and IGRT techniques, in all centres as standard and use of deep inspiration breath hold (DIBH) organ sparing techniques for all left-sided and now right-sided breast cancer. We also offer spacer insertions to eligible patients to reduce rectal damage after prostate cancer radiotherapy
• Theranostics, innovative ‘seek and destroy’ treatment for advanced metastatic prostate cancer 
• Comprehensive systemic anti-cancer therapy (SACT) service with dedicated clinical nurse specialists and private chemotherapy suites 
• Advanced diagnostics, including 3T MRI, SPECT/CT, mpMRI and PET/CT 
• Rapid access pathways and diagnostic clinics for breast, haematology, head and neck and urology

Our state-of-the-art MR Linac machines are currently available at our centres in Oxford, London and Surrey. 

Our new centre in Leeds will open in January 2027, setting a new standard in adaptive radiotherapy in the UK.  The centre will have the unique ability to personalise radiotherapy in real-time, using both MRI and CT imaging, offering patients treatment precisely tailored to their specific cancer.  This fourth MR Linac in our network, means we have the largest fleet of these machines in the UK, providing patients easy access to this innovative technology wherever they are in the country.

As at September 2026 we have treated more than 2,800 patients across a range of tumour types using our MR Linacs, including complex, difficult-to-treat tumours in the central lung, liver and pancreas. We believe we were also the first to deliver MRI-guided fully adapted stereotactic radiotherapy treatment for renal cancer in the UK.  

We are a patient-first organisation and aim to provide exceptional care in everything we do. Many of our centres are rated good by the CQC and carry the Macmillan Quality Environment Mark (MQEM). We embed integrated cancer care into our pathways and provide a comprehensive, consultant-led emotional and physical support package of life-changing therapies that have been proven to alleviate cancer-related concerns and improve treatment outcomes. Therapies include exercise medicine from our qualified physiotherapists and counselling, as well as massage, acupuncture and reflexology, through the charity, Penny Brohn UK. This is at no extra cost to our patients or their insurers. 

We can help patients with their insurance claims and explain the costs associated with their treatment. We can also provide help with transport, depending on treatment and locations, when required. 

I wasn’t prepared to wait and see if my cancer got worse

- Doug

Patient safety is at the heart of what we do. At GenesisCare, through regulation and governance, we deliver the latest evidence-based treatments in a safe and high-quality environment.  

Our Clinical Governance Committee sets safe and effective treatment protocols, reviews pathways, manages risk and works with the CQC. All consultant practising privileges are reviewed and continuously validated by our Medical Advisory Committee. Cases outside standard protocol are referred to our Clinical Advisory Team to peer review and recommend the best treatment plan.  

Our Clinical Leaders Forum consists of leading practitioners in all fields of oncology working with GenesisCare to spearhead best practice and innovations and expand our referral network.  

Our Clinical Reference Groups specialising in breast, prostate, SABR and neuro-oncology oversee the continuous process of clinical evaluation, using peer-group collaboration and data-driven insights to design and implement standardised treatment protocols across our centres. 

Patients can be referred from anywhere in the UK and all those with a new diagnosis of cancer are discussed at an MDT meeting. We are expanding our MDT service to facilitate peer review, collaborative decision-making and clinician support.